-
Small antibody fragment shows potential for non-hormonal contraception
15 Apr 2025 12:56 GMT
… shows how a small antibody fragment can block fertilization … describe how a modified antibody fragment can block fertilization … Fc region of the full antibody, scFV minimises potential side … as an alternative, but antibodies were deemed unsuitable due to …
-
Efficient separation and analysis of antibody fragments and their drug conjugates
15 Apr 2025 07:26 GMT
… GmbH
Alongside monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs) antibody fragments and … of intact antibodies. Due to their significantly
smaller size, antibody fragments require …
-
Roche's bispecific antibody, Columvi receives European approval for diffuse large B─cell lymphoma after initial therapy
15 Apr 2025 05:18 GMT
… ’s industry-leading CD20xCD3 bispecific antibody programme. Together with the clinical … CD20xCD3 T-cell-engaging bispecific antibody clinical development programme that also … includes T-cell engaging bispecific antibody cevostamab, targeting both FcRH5 and …
-
VIDEO: Antibody-drug conjugates show promise in gynecologic cancers
14 Apr 2025 21:49 GMT
… DeBernardo, MD, shares
insight on antibody-drug conjugates as treatment for … ’s
Cancer.
“We have five antibody-drug conjugates that are FDA … concept where we
take an antibody to a target on the …
-
ProBio to Present Data on Its CD3 Agonistic Single Domain Antibody Platform for Accelerated Development of T Cell Engager Multi-Specific Antibodies
14 Apr 2025 21:25 GMT
… commitment to advancing innovative antibody-based solutions for cancer … Multi-Specific Antibodies
Session Title: Therapeutic Antibodies, Including Engineered Antibodies 2
Session … utilizes an optimized single-domain antibody (sdAb) targeting CD3, overcoming …
-
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
14 Apr 2025 16:04 GMT
-
Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy
14 Apr 2025 12:53 GMT
… Columvi combination is a bispecific antibody regimen available for people with …
-
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
14 Apr 2025 12:54 GMT
Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or potentially replace current animal testing requirements with new approaches designed to improve drug safety and accelerate the …
-
Cancer Monoclonal Antibody Market Set to Reach USD 150.0 Billion, with a Healthy 3.68% CAGR Till Forecasts 2035
14 Apr 2025 09:58 GMT
… Type Outlook
Naked Antibodies
Conjugated Antibodies
Bispecific Antibodies
Humanized Antibodies
Cancer Monoclonal Antibody Market Application …
-
ABION signs term sheet for potential $800 mil. antibody licensing deal
14 Apr 2025 09:42 GMT
… of monoclonal and bispecific antibody candidates, including its … is designed to trigger antibody-dependent cellular cytotoxicity (ADCC … including ADCs and bispecific antibodies, for the treatment of … sheet reportedly covers three antibody-based assets, including …